Cite
Associations of Clinical and Molecular Characteristics with the Response to Immune Checkpoint Blockade in Advanced Gastric Cancers.
MLA
Xu, Xiaoqing, et al. “Associations of Clinical and Molecular Characteristics with the Response to Immune Checkpoint Blockade in Advanced Gastric Cancers.” Journal of Oncology, Mar. 2022, pp. 1–10. EBSCOhost, https://doi.org/10.1155/2022/2162229.
APA
Xu, X., Li, J., Gao, Y., Lv, W., Wei, Q., Tang, X., Hu, J., Yuan, X., Wu, W., Zhang, L., Luo, C., Chen, L., Ying, J., Zhu, X., & Xu, Q. (2022). Associations of Clinical and Molecular Characteristics with the Response to Immune Checkpoint Blockade in Advanced Gastric Cancers. Journal of Oncology, 1–10. https://doi.org/10.1155/2022/2162229
Chicago
Xu, Xiaoqing, Jingjing Li, Yiding Gao, Wangxia Lv, Qing Wei, Xiaowan Tang, Jinlin Hu, et al. 2022. “Associations of Clinical and Molecular Characteristics with the Response to Immune Checkpoint Blockade in Advanced Gastric Cancers.” Journal of Oncology, March, 1–10. doi:10.1155/2022/2162229.